Evidence map›Paper›PMID 36671061›Full record

ArticleAntioxidants (Basel, Switzerland)2023

Obesity Affects Maternal and Neonatal HDL Metabolism and Function.

Julia T Stadler, Mireille N M van Poppel, Christian Wadsack, Michael Holzer, Anja Pammer, David Simmons, David Hill, Gernot Desoye, Gunther Marsche, Dali Core Investigator Group

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Julia T StadlerDivision of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-1156-631X
Mireille N M van PoppelInstitute of Human Movement Science, Sport and Health, University of Graz, 8010 Graz, Austria.ORCID 0000-0001-5694-4324
Christian WadsackDepartment of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0002-5589-8642
Michael HolzerDivision of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0003-3434-703X
Anja PammerDivision of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.
David SimmonsMacarthur Clinical School, Western Sydney University, Sydney, NSW 2560, Australia.ORCID 0000-0003-0560-0761
David HillLawson Health Research Institute, London, ON N6C 2R5, Canada.ORCID 0000-0002-2490-5678
Gernot DesoyeDepartment of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0002-5715-3230
Gunther MarscheDivision of Pharmacology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-2422-5381
Dali Core Investigator Group
Medical University of Graz · ATLawson Health Research Institute · CAUniversity of Graz · ATWestern Sydney University · AU

Funding

Austrian Science Fund FWF DOC 31
6 · The paper itself

Abstract

Pregravid obesity is one of the major risk factors for pregnancy complications such as gestational diabetes mellitus (GDM) and an increased risk of cardiovascular events in children of affected mothers. However, the biological mechanisms that underpin these adverse outcomes are not well understood. High-density lipoproteins (HDLs) are antiatherogenic by promoting the efflux of cholesterol from macrophages and by suppression of inflammation. Functional impairment of HDLs in obese and GDM-complicated pregnancies may have long-term effects on maternal and offspring health. In the present study, we assessed metrics of HDL function in sera of pregnant women with overweight/obesity of the DALI lifestyle trial (prepregnancy BMI ≥ 29 kg/m2) and women with normal weight (prepregnancy BMI < 25 kg/m2), as well as HDL functionalities in cord blood at delivery. We observed that pregravid obesity was associated with impaired serum antioxidative capacity and lecithin−cholesterol acyltransferase activity in both mothers and offspring, whereas maternal HDL cholesterol efflux capacity was increased. Interestingly, functionalities of maternal and fetal HDL correlated robustly. GDM did not significantly further alter the parameters of HDL function and metabolism in women with obesity, so obesity itself appears to have a major impact on HDL functionality in mothers and their offspring.

Indexed as

antioxidative capacitycholesterol efflux capacitygestational diabetes mellitusLCATobesityparaoxonase-1pregnancy

Identifiers

PMID36671061
PMCPMC9854613
OpenAlexW4316466507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.